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Key messages
 ► The need for second-trimester abortion 
services does not diminish, even with 
expansion of first-trimester abortion 
services.
 ► Poorer, younger women are more at risk 
for second-trimester abortion (versus 
first-trimester).
 ► States with health and fetal anomaly 
legal exceptions do not have higher 
utilisation of second-trimester abortion 
services, indicating under-utilisation of 
these legal exceptions.
ABSTRACT
Background Data on utilisation of in-facility 
second-trimester abortion services are sparse. 
We describe temporal and geographical trends in 
utilisation of in-facility second-trimester abortion 
services across Mexico.
Methods We used 2007–2015 data from Mexico’s 
Automated Hospital Discharge System (SAEH) 
to identify second-trimester abortive events (ICD 
O02-O08) in public hospitals across Mexico’s 
32 states. We described utilisation, calculated 
rates using population data, and used logistic 
regression to identify woman- and state-level 
factors (municipality-level marginalisation, state-
level abortion law) associated with utilisation of 
second-trimester versus first-trimester services.
Results We identified 145 956 second-trimester 
abortions, or 13.4% of total documented 
hospitalizations for abortion between 2007 to 
2015. The annual utilisation rate of second-
trimester abortion remained constant, between 
0.5 to 0.6 per 1000 women aged 15–44 
years. Women living in highly marginalised 
municipalities had 1.43 higher odds of utilising 
abortions services in their second versus their 
first trimester, when compared with women in 
municipalities with low marginalisation (95% CI 
1.18 to 1.73). Living in a state with a health or 
fetal anomaly exception to abortion restrictions 
was not associated with higher utilisation of 
second-trimester abortion services.
Conclusions Our results suggest there is a need 
for all types of second-trimester abortion services 
in Mexico. To improve health outcomes for 
Mexican women, especially the most vulnerable, 
access to safe second-trimester abortion services 
must be ensured through the implementation of 
current legal exceptions and renewed attention 
to the training of healthcare providers.
InTRoduCTIon
Overall, 10%–15% of abortions world-
wide occur in the second trimester, yet 
they account for a disproportionate 
number of maternal deaths when provided 
under unsafe conditions.1–3 Reasons 
women need second-trimester abortion 
services vary, but include late diagnosis of 
fetal anomalies, delays in recognition of 
pregnancy, newly diagnosed or worsening 
maternal health conditions, and delays 
associated with access to care.2–4 Access 
to safe second-trimester abortion is an 
essential part of global efforts to reduce 
maternal morbidity and mortality, yet 
access is restricted in many parts of the 
world.2
Two-thirds of countries with laws regu-
lating second-trimester abortion allow it 
only to save the woman’s life.3 While many 
countries do have exceptions permitting 
second-trimester abortion, such as the 
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fetal anomalies, or socioeconomic reasons, access to 
services under these exceptions varies by country.5–7 
The unmet need for second-trimester abortion remains 
unknown since many national vital statistics systems 
do not specifically capture incidence of second-tri-
mester abortions.2
In Mexico, abortion laws are determined at the 
state level. In Mexico City, one of Mexico’s 32 states, 
women have had access to first-trimester abortion in 
the private and public sectors since 2007.8 In Mexico’s 
31 other states, abortion at all gestational ages remains 
restricted.7 Gestational age (GA) measures the age of a 
pregnancy and is reported in weeks. Rape is the only 
circumstance for which abortion is legally permitted at 
the federal level.9 Other grounds for legal access vary 
by state. For example, 14 states permit abortion when 
the health of a woman is at risk, while 16 permit abor-
tion in cases of fetal anomalies.10
Previous research on abortion in Mexico has esti-
mated incidence using indirect methods11–13 or focused 
on Mexico City’s pubic abortion programme.8 14 15 
Data on in-facility second-trimester abortion is lacking; 
yet, it is critical to measure documented service provi-
sion in order to understand demand for abortion 
services and population health outcomes. We used 
Mexico’s hospital discharge register to describe utili-
sation of second-trimester spontaneous, induced, and 




We used 2007–2015 data from Mexico’s hospital 
discharge system, SAEH (Subsistema Automatizado 
de Egresos Hospitalarios).16 Hospital discharge was 
defined as the exit of a patient from inpatient services 
(at least one night in the facility). All facilities included 
in this dataset are operated by national and state minis-
tries of health (Secretaría de Salud, SSA). These facilities 
largely serve individuals without insurance or covered 
by Seguro Popular, a public insurance programme 
for the unemployed, self-employed, or those without 
access to employment-based social security.17 These 
government facilities accounted for an estimated 76% 
of the country’s total inpatient post-abortion cases in 
2009.12
We built a dataset of obstetric events (births and 
abortions). Each discharge record includes up to six 
international Classification of Diagnosis Codes Version 
10 (ICD-10) codes for reason for admission. We iden-
tified abortive events using ICD-10 codes O02-O08 
(online supplementary web appendix table A1); we 
excluded ectopic and molar pregnancies with an abor-
tive outcome, ICD-10 codes O00 and O01. We iden-
tified all types of abortion care through these hospital 
records; although the codes theoretically provide a 
way to differentiate between induced and spontaneous 
abortions, nearly 70% of second-trimester abortions 
were coded as ‘O06 Unspecified abortion’, making 
it difficult to differentiate between type of abortion. 
Therefore, we classified all abortive events (ICD codes 
O02-O08) as abortion for this analysis. In order to 
comprehensively capture second-trimester abortions, 
we also included women who had abortion codes for 
up to six discharge diagnosis codes (N=894; 0.6% 
of total sample (online supplementary web appendix 
table A2)). Additional abortions that may not have 
been identified using ICD-10 diagnostic codes were 
identified using a ‘type of attention’ checkbox in the 
SAEH records, which indicates whether an abortion 
or a delivery was performed (N=3974; 2.7% of total 
sample).
Among the records between 2007–2015, 22% (238 
972) were missing GA (online supplementary web 
appendix table A3). Records missing GA were dispro-
portionately from women in less marginalised urban 
areas, such as Mexico City. There were few abortions 
identified after 20 weeks; under international and 
national definitions, spontaneous or induced abor-
tions after 20 weeks are classified as ‘stillbirths’.18 
The SAEH records also include the following vari-
ables: age, municipality and state of residence, parity, 
hospital of admission, and length of hospital stay. We 
defined reproductive age as women aged 15–44 years.
We used 2010 population estimates of women 
aged 15–44 years from the Mexican government’s 
population agency, Consejo Nacional de Población 
(CONAPO),19 at the state and national level to 
calculate rates. We also used the 2010 municipali-
ty-level marginalisation index, a measure of commu-
nity-level socioeconomic status.20 The index includes 
information about education, housing, income, and 
population density and is generated using principal 
components analysis.21 We classified municipalities 
into five groups: very low, low, medium, high, and 
very high marginalisation. We merged the marginal-
isation index into the individual-level discharge data 
using the residence municipality of the woman. We 
also categorised states into four groups based on the 
percentage of the population living in poverty in 2014 
as reported by The National Council for the Evalua-
tion of Social Development Policy (CONEVAL)21 and 
previous literature.22
We included information on state-level legal excep-
tions for abortion categorised as binary variables based 
on whether a state had exceptions for health of the 
woman or fetal anomaly in their penal code.10 Finally, 
we merged in hospital tier of specialisation (primary, 
secondary and tertiary).23 24 All data sources were 
publicly available and downloadable (online supple-
mentary web appendix table A4).
Analysis
We calculated second-trimester abortion hospitali-
sation rates per year per 1000 women aged 15–44 
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Table 1 Characteristics of women receiving in-hospital 
second-trimester abortions, Mexico 2007–2015
Characteristic
Frequency (n)
(N=145 956) Percentage (%)
Age (years)
  <18 18 397 12.60
  18–25 66 924 45.42
  26–30 27 626 18.93
  31–40 30 208 20.70
  >40 3421 2.35
Length of hospital stay (days)
  0 2576 1.76
  1 102 609 70.30
  2 27 124 18.58
  3+ 13 647 9.35
Municipality-level marginalisation index*
  Very low 73 660 50.55
  Low 23 719 16.28
  Medium 33 250 22.82
  High 8139 5.59
  Very high 6947 4.77
*Very high marginalisation represents the poorest group, while very low 
marginalisation represents the wealthiest group.
second-trimester abortion hospitalisation rates across 
Mexico by state, and by the presence of state-level 
health or fetal anomaly exception laws.
We next examined changes in mean and median GA 
of second-trimester abortions over time. We exam-
ined trends nationally and in Mexico City versus other 
Mexican states. Since Mexico City has legal first-tri-
mester abortion services, we hypothesised that trends 
in second-trimester GA would be lower in Mexico 
City due to availability of first-trimester abortion.
Finally, we identified factors associated with utili-
sation of hospital-based second-trimester (vs first-tri-
mester) abortion using a logistic regression model. We 
included age, parity, municipality-level marginalisa-
tion, state-level health and fetal anomaly exceptions, 
and hospital specialisation. We assessed model robust-
ness by running models with different covariates, such 
as hospital bed size, women’s education, and maternal 
mortality rate; results were robust and we show only 
the final model. We estimated robust standard errors to 
account for non-independence of observations within 
hospitals using the ‘cluster’ option in STATA version 
15 (StataCorp, College Station, TX, USA).25
Patient and public involvement
There was no patient involvement in this secondary 
data analysis.
ReSulTS
Among 1 083 803 induced and spontaneous abor-
tions documented in the SAEH hospitalisation records 
between 2007 and 2015, we identified 145 956 
(13.4%) second-trimester abortions. The majority 
of second-trimester abortions (70%) were classified 
as ICD-10 code O06 (‘unspecified’). Nearly 60% of 
second-trimester abortions were among women aged 
≤25 years, and only 2.4% occurred among women 
aged >40 years (table 1). Most (70%) women who 
had a second-trimester abortion were hospitalised for 
1 day. Over 50% of reported second-trimester abor-
tions occurred in the least marginalised municipalities 
(table 1). Overall, 20.2% of second-trimester abor-
tions were performed in tertiary care hospitals, 78.4% 
in secondary care hospitals, and 1.4% in primary 
health facilities. However, in Mexico City, 51.2% of 
second-trimester abortions were performed in special-
ised hospitals, while in the poorer states of Guerrero, 
Oaxaca and Chiapas, only 1.6% of second-trimester 
abortions were performed in specialised hospitals 
(online supplementary web appendix table A5).
The annual nationwide hospitalisation rate of 
second-trimester abortion services remained stable, 
between 0.5 to 0.6 per 1000 women of reproduc-
tive age (15–44 years) over the study period. In our 
spatial analysis of second-trimester induced and spon-
taneous abortion hospitalisations, there was clustering 
of higher rates of hospitalisation in the central and 
southern parts of Mexico (figure 1). The states of 
Zacatecas and Durango had the highest rates of util-
isation of hospital-based, second-trimester abortion 
services (1.1 and 0.89 per 1000 women, respectively) 
followed by predominantly southern states, including 
Tlaxcala and Guerrero. The northeastern states, 
including Coahuila, Nuevo León and Tamaulipas, had 
some of the lowest rates of utilisation of second-tri-
mester abortion services.
No relationship between legal exceptions that permit 
abortion and documented utilisation of public, hospi-
tal-based abortion services was detected. In states with 
a health exception (figure 2), utilisation rates of hospi-
tal-based second-trimester abortion were 0.30 to 1.10 
per 1000 women; rates were similar in states without a 
health exception (0.2 to 0.9). Among states with fetal 
anomaly exceptions, the hospitalisation rater varied 
between 0.21 and 0.77 per 1000 women, and did not 
differ based on region (figure 2).
The majority (62%) of second-trimester abortions 
were performed between 13 and 16 weeks, 38% 
occurred between 17 and 20 weeks, and <1% from 
21 to 24 weeks. In 2007, mean GA of second-trimester 
abortion patients in Mexico City was 18.11 weeks 
(95% CI 18.01 to 18.21), 1.82 weeks higher than the 
other Mexican states at 16.29 weeks (95% CI 16.25 
to 16.34). In 2009, this difference narrowed to 0.12 
weeks, and remained constant for the rest of the study 
period. However, overall mean GA remained margin-
ally higher in Mexico City (16.6) compared with the 
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Figure 1 Second-trimester abortion utilisation rate per 1000 women aged 15–44 years in 2015 for individual Mexican states
Figure 2 Second-trimester abortion utilisation rate per 1000 women aged 15–44 years in 2015 in Mexican states with health exceptions and fetal 
anomaly exceptions.
In multivariable analyses, adolescents were more 
likely than older women to present for abortion 
services in the second trimester compared with the 
first trimester (odds ratio (OR) 1.07, 95% CI 1.04 to 
1.11) (figure 3). Women living in municipalities with 
high levels of marginalisation had higher odds of util-
ising abortion services in their second trimester versus 
first trimester compared with women living in munici-
palities with lower marginalisation (OR 1.43, 95% CI 
1.18 to 1.73). Living in a state with a health or fetal 
anomaly exception was not associated with utilisation 
of second-trimester versus first-trimester services.
dISCuSSIon
In this study, we present novel data on the utilisation of 
second-trimester abortion services in the public sector 
in Mexico. We found that women seek care in health 
facilities for second-trimester abortion care, including 
spontaneous, induced, and post-abortion services, even 
in places where abortion is highly restricted, although 
not at the rates that might be expected.2 Although 
second-trimester induced abortion is largely illegal 
throughout Mexico, some women are able to access 
abortion services under the available exceptions; many 




ber 2, 2019 by guest. Protected by copyright.
http://jfprhc.bmj.com/
BM
J Sex Reprod Health: first published as 10.1136/bmjsrh-2018-200300 on 14 August 2019. Downloaded from 
Alexander LT, et al. BMJ Sex Reprod Health 2019;0:1–7. doi:10.1136/bmjsrh-2018-200300 5
Research
Figure 3 Factors associated with second-trimester abortion versus first-trimester abortion care. OR, odds ratio; Ref., reference.
We found the average hospitalisation rate for 
second-trimester abortions was 0.57 per 1000 women, 
and 13.4% of total hospital-based abortions occurred 
in the second trimester. Existing estimates of util-
isation of abortion services in Mexico range from 
7.3 per 1000 women26 to 38 per 1000 women aged 
15–44 years.12 Under the assumption second-trimester 
induced and spontaneous abortions account for ~15% 
of total abortions,2 27 we might expect the utilisation 
of second-trimester abortion to range from 1.1 to 5.7 
per 1000 women. We found consistent utilisation of 
second-trimester abortion services during the study 
period, including in Mexico City, even following 
liberalisation of first-trimester abortion in the capital 
in 2007. However, we did detect a slight decline in 
GA at the time of second-trimester abortion among 
women in Mexico City after 2007, which may be due 
to improved access to first-trimester abortion. Our 
results demonstrate the need for second-trimester 
abortion services remains present, even with expan-
sion of first-trimester abortion services.
Furthermore, we found health and fetal anomaly 
exceptions in the state laws were not associated 
with higher utilisation of second-trimester abortion 
services. The potential under-utilisation of second-tri-
mester abortion services may be due to poor imple-
mentation of all legal exceptions.7 For example, while 
Jalisco passed a law in 2009 that mandated institutions 
to provide abortion in cases of rape, there have only 
been 16 cases documented.28 This type of low utilisa-
tion was reflected in our study; women living in states 
with legal exceptions for health or fetal anomaly were 
no more likely to utilise second-trimester services than 
women living in states without these exceptions. There 
remains widespread under-utilisation of legal excep-
tions, likely due to lack of information and training 
among providers, poor dissemination of information 
to women, and a continued environment of criminal-
isation.7 29 30
Our results support other evidence that Mexico’s 
most vulnerable women are often disproportionately 
affected by obstacles to obstetric or prenatal care.14 
This finding has been reflected in other settings, where 
younger, poorer and more disenfranchised women 
were more likely to seek second-trimester abor-
tions.4 14 31–33 In our study, women in less marginal-
ised municipalities comprised half of our sample of 
second-trimester abortions, but had lower odds of 
presenting for second-trimester (versus first-trimester) 
abortion services. Adolescents had higher odds of 
presenting for second-trimester (versus first-trimester) 
abortion services when compared with older women.
Our study has limitations; Mexico is among a few 
low- and middle-income countries with robust health 
information systems, but secondary health services 
data are limited. We included all abortions – sponta-
neous and induced – and were not able to differentiate 
between them. Second, this is not a study of second-tri-
mester abortion incidence, but of documented util-
isation in the public sector. Our results may not be 
generalisable to private or employment-based health 
sectors or abortions that occur out-of-facility.34–36 The 
SAEH data contain limited individual-level sociodemo-
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with facility, municipality and state-level character-
istics to partially address this limitation of the data. 
Fourth, in our comparison of women seeking first-tri-
mester versus second-trimester abortions, our sample 
of first-trimester abortions is limited by the fact that it 
does not include any outpatient services from Mexico 
City’s legal first-trimester abortion programme. 
However, we found similar results when running our 
model with and without data from Mexico City. In 
addition, 22% of records were missing GA; improve-
ments in the documentation of GA would increase our 
understanding of the timing of abortion in Mexico.
In our study, we leveraged objective clinical data 
to report on in-facility second-trimester spontaneous 
and induced abortion across the public sector in a 
low- and middle-income country where abortion is 
restricted. We found the average hospitalisation rate 
for second-trimester abortions was 0.57 per 1000 
women, and 13.4% of total hospital-based abortions 
occurred in the second trimester. We highlight there 
is a need for second-trimester abortion services in 
Mexico. To improve health outcomes for Mexican 
women, especially the most vulnerable, access to safe 
second-trimester abortion services must be ensured 
through the implementation of current legal excep-
tions and renewed attention to provider training.
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